1 / 13

January 2008

January 2008. May 2008. Mission Statement. BioPad™’s mission is to become a world leader in the field of pre-natal care by making consumer-based medical devices that improve the pregnancy experience for women and their families. The fetus care.

chanel
Download Presentation

January 2008

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. January 2008 May 2008

  2. Mission Statement BioPad™’s mission is to become a world leader in the field of pre-natal care by making consumer-based medical devices that improve the pregnancy experience for women and their families. The fetus care

  3. BioPad makes home-use fetal activity detectors and dataloggers Products are passiveand non-radiating Small, convenient, elegant and hygienic Can be used anywhere, anytime. Introducing Biopad’s Fetal Monitors The fetus care

  4. Why Fetal Movements ? • Scientific evidence suggests fetal activity is a clear indicator of wellbeing • A common medical practice is a daily manual fetal kick count by the mother (‘count to 10’) • Kick count is directly linked to lower stillbirth rates (20%-30%) • Research also shows that kick counting improves the pregnancyexperience The fetus care

  5. Common Poster at Doctors’ Offices The fetus care

  6. Customer Needs • Monitoring • Reassurance • Procedure • Discerning • Bonding • Dialog • Connecting The fetus care

  7. The Products – Kicker Ticker 2 • Medical device that requires FDA approval • Consists of device (for single pregnancy) and disposable pad (one for each test) • Provides automatic and accurate monitoring • Counts and stores fetal movements (trends) • Shows real-time results • Sounds & light indications • Data output (via USB) to be shared with doctor • Each session lasts 20 minutes and can take place anywhere The fetus care

  8. Prototype Testing Completed Successfully! The fetus care The fetus care

  9. The Products – Kicker Ticker 1 • Non-medical, pregnancy experience focused • Intended to share movements with family members and friends • The Companion Egg™ responds to movements with tactile and light elements, creating tangible “event” • Does not require FDA approval • Fast time to market Movements Light Sounds The fetus care

  10. The Market is Significant The fetus care

  11. Substantial Sales Potential • KT2 costs to woman - $120 • KT1 costs to woman- $80 • Family set - $150 (Includes sensor & 3 Companion Eggs™) • Potential of +$100 million in income in year 5 of operations

  12. $2 - $3 million second round financing Strategic partnerships: Manufacturing Distribution Marketing Company Needs The fetus care

  13. Hanoch Kaftzan BioPad CEO T: 972.3.6093085 M: 972.52.6299629 F:972.3.6093089 Ayalon House, 16th floor 12 Abba Hillel St. Ramat Gan PO Box 25290, Tel Aviv 61251

More Related